AstraZeneca Puts Leading COVID-19 Vaccine Trial on Hold Over Safety Concern

(Reuters) - AstraZeneca Plc on Tuesday said it has paused a late-stage trial of one of the leading COVID-19 vaccine candidates after an unexplained illness in a study participant. "Our standard review process was triggered and we voluntarily paused ...

from Google Alert - Business https://ift.tt/2R9OQdc
(Reuters) - AstraZeneca Plc on Tuesday said it has paused a late-stage trial of one of the leading COVID-19 vaccine candidates after an unexplained illness in a study participant. "Our standard review process was triggered and we voluntarily paused ... https://ift.tt/eA8V8J

Comments

Popular posts from this blog

Jobless Rate Drops

Electrolytic Fixed Power Capacitors Market Competitive intelligence & regional outlook 2020

USU project among finalists for $3 million solar energy tech prize